Efficacy and Safety of Dapagliflozin for the Hospital Management of Patients With Type 2 Diabetes

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The purpose of the trial is to examine whether treatment with dapagliflozin plus insulin as compared with insulin alone (basal-bolus insulin) will result in similar blood glucose control and similar rate of complications in patients with diabetes, who are admitted to a hospital in a noncritical setting
Epistemonikos ID: 1e193b49bd22290a36f37499f03697c4f2191edd
First added on: May 13, 2024